“More Real than Real:” A Psychiatrist Discusses DMT
Oregon's recent vote to legalize psilocybin therapy, and the IPO of pharmaceutial psilocybin company Compass Pathways are just the latest signs of surging interest and newfound respectability for psychedelics.
The psychedelic compound DMT (Dimethyltryptamine) isn't as well known as psilocybin. But it is renowned in some circles for inducing an experience that Dr. Rick Strassman, a psychiatrist and professor at the University of New Mexico School of Medicine, described as "more real than real," while only lasting about . . .
Log in or become a WeedWeek Member to read this article.
